1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Product Definition deadline is Jun 18, 2026; Preclinical EOI window Sep 14 - Oct 2, 2026; Regulatory EOI is rolling.
"Catalyze Program: Product Definition" is currently closed and not accepting applications.
Catalyze Program: Product Definition is sponsored by National Heart, Lung, and Blood Institute (NHLBI). The Catalyze Program aims to transform basic scientific discoveries into viable therapeutics, devices, and diagnostics for heart, lung, blood, and sleep diseases. The 'Product Definition' application supports early product definition studies and safety testing.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
NHLBI Catalyze Program : Transforming basic scientific discoveries into viable therapeutics, devices, and diagnostics to treat heart, lung, blood, and sleep diseases and disorders Drives development of new potential heart, lung, blood, and sleep (HLBS)-related therapies and cures by supporting early product definition studies and safety testing Supports development of novel, enabling platform technologies that catalyze next-generation, predictive, diagnostic, and therapeutic products Unique funding strategy to leverage federal investment with matching commitments and flexibility to adjust to technical challenges A seamless continuum of programs to advance promising HLBS-related technologies from validation to first-in-human trials Milestone-driven project management and support to mitigate technical risk Evaluation and oversight to adjust the program based on trends and challenges, and to share best practices The Catalyze Program provides a bridge from basic research to clinical research across the entire heart, lung, blood, and sleep research spectrum, and trains a scientific workforce fluent in product development and entrepreneurship.
Learn more about Catalyze Submit your email address so that we can contact you with Catalyze updates: Catalyze was established by the National Heart, Lung, and Blood Institute (NHLBI) within the National Institutes of Health (NIH). This research was, in part, funded by the National Institutes of Health (NIH) Agreement OT2 HL157844-01.
The views and conclusions contained in this document are those of the authors and should not be interpreted as representing the official policies, either expressed or implied, of the NIH.
According to the current listing, eligibility includes: Universities and academic innovators with projects focused on developing new heart, lung, blood, and sleep (HLBS)-related therapies, devices, and diagnostics. Confirm the full requirements in the official notice before applying.
The published deadline was June 18, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Catalyze Program: Product Definition is funded by National Heart, Lung, and Blood Institute (NHLBI). Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
Five NHLBI Catalyze Product Definition RFAs — HL-26-016 through HL-26-020 — carry an October 21, 2026 receipt date, budget caps of $300,000 to $400,000 per year, and roughly 8 new awards annually. The science is not the gate. An Accelerator Partner and a 0.25:1 non-federal cost match are, and both take longer to line up than the nine weeks you have left.
Read articleThe $46M FSHARP program is creating shelf-stable synthetic blood from freeze-dried components. A new SWiFT SBIR topic opened May 6 for autonomous field transfusion devices. What grant seekers in biomedical engineering need to know.
Read articleDARPA MTO opened six FY26 SBIR topics on May 27 with a June 24 deadline — nanopore proteomics, compact RF filters, 800°C ICs, passive thermal spreaders, radiation-hardened codesign, and low-resource computing. The topics read like a wishlist for the next decade of contested-environment microelectronics. Here is what each one is actually asking for, and how small businesses should triage the four-week window.
Read article